These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5718178)

  • 1. [Intermittent chemotherapy].
    Zierski M
    Gruzlica; 1968 Dec; 36(12):1241-6. PubMed ID: 5718178
    [No Abstract]   [Full Text] [Related]  

  • 2. Daily and intermittent regimens: third IUAT chemotherapy investigation. A controlled trial of three regimens of self-administered and supervised chemotherapy for pulmonary tuberculosis. Clinical aspects.
    Bignall JR
    Bull Int Union Tuberc; 1970 Jun; 43():253-4. PubMed ID: 4193293
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of intermittent chemotherapy of patients with tuberculosis].
    Toushek I; Papezhova E; Trnka L
    Probl Tuberk; 1979 Jul; (7):21-4. PubMed ID: 504117
    [No Abstract]   [Full Text] [Related]  

  • 4. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical aspects and outcome of recurrent pulmonary tuberculosis].
    Krasnov VA; Potashova VA; Zyrianova TV; Naryshkina SL
    Probl Tuberk; 1993; (5):14-6. PubMed ID: 8295875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [One-year results of initial therapy of cavernous pulmonary tuberculosis with isoniazid, streptomycin and ethionamide].
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Gruzlica; 1965 Jul; 33(7):565-70. PubMed ID: 5849562
    [No Abstract]   [Full Text] [Related]  

  • 7. Three initial streptomycin supplements to standard isoniazid-thiacetazone chemotherapy. East African-British Medical Research Council investigation.
    Kent PW
    Bull Int Union Tuberc; 1970 Jun; 43():256-60. PubMed ID: 4193294
    [No Abstract]   [Full Text] [Related]  

  • 8. Short course chemotherapy of pulmonary tuberculosis and its possible impact on epidemiology of disease.
    Mehrotra ML; Gautam KD; Chaube CK
    Indian J Chest Dis Allied Sci; 1982; 24(2-3):195-202. PubMed ID: 7166353
    [No Abstract]   [Full Text] [Related]  

  • 9. Intermittent ambulatory treatment of tuberculosis once a week, preceded by a 30-day intensive hospital treatment.
    Calvo AS; Serrano T; Rivas HD; Iturbe P
    Bull Int Union Tuberc; 1968 Dec; 41():331-4. PubMed ID: 5710258
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of classical chemotherapy in in-patient and out-patient treatment of freshly detected pulmonary tuberculosis].
    Kuczborski S
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):339-41. PubMed ID: 5897864
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of chemotherapy in patients with primary distructive tuberculosis].
    Novikova NA
    Probl Tuberk; 1967; 45(5):21-6. PubMed ID: 5617940
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of one-year chemotherapy in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Janczy S; Buraczewska M; Korlakowski J; Zych D; Krychniak W
    Pol Med J; 1966; 5(3):526-32. PubMed ID: 5920266
    [No Abstract]   [Full Text] [Related]  

  • 13. The long-term use of intermittent streptomycin plus isoniazid in the treatment of tuberculosis.
    Poole G; Stradling P
    Tubercle; 1965 Sep; 46(3):290-3. PubMed ID: 5860974
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmoary tubercular lesions modified by chemotherapy.
    Goyl RK; Arora HL; Sharma ML
    J Indian Med Assoc; 1969 Feb; 52(3):101-3. PubMed ID: 5797826
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of corticotherapy on the residual pulmonary lesions after antitubercular chemotherapy].
    Araszkiewicz W
    Gruzlica; 1969 Mar; 37(3):223-34. PubMed ID: 5814946
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative evaluation of antimicrobial properties of actinomyces, isolated in patients with pulmonary tuberculosis treated with phthivazid and streptomycin].
    Nikiforchin RN
    Probl Tuberk; 1971; 49(7):66-71. PubMed ID: 5169485
    [No Abstract]   [Full Text] [Related]  

  • 17. Experiences with ethionamide in chronic drug-failure cases of pulmonary tuberculosis.
    Mitra A
    Minerva Medicoleg; 1965; 85(3):29-33. PubMed ID: 5879932
    [No Abstract]   [Full Text] [Related]  

  • 18. Trial of sanatorium treatment including a comparison of standard and intermittent continuation chemotherapy: Central Bohemian Tuberculosis Services-WHO-British Medical Research Council investigation.
    Polansky F
    Bull Int Union Tuberc; 1970 Jun; 43():295-302. PubMed ID: 5425558
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of INH- and streptomycin-resistant patients].
    Böszörményi M; Schweiger O
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):329-31. PubMed ID: 5897861
    [No Abstract]   [Full Text] [Related]  

  • 20. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.